雅虎香港 搜尋

  1. 相關搜尋:

搜尋結果

  1. Search company information, interaction, images & medical diagnosis. The most comprehensive database of medicines available in China, Hong Kong, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Thailand, Indonesia and India Register for a MIMS account ...

  2. Search drug information, interaction, images & medical diagnosis. The most comprehensive database of medicines available in China, Hong Kong, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Thailand, Indonesia and India Register for a MIMS account and ...

  3. Description. Tablet: AMK 375: Each tablet contains 250 mg of amoxicillin and 125 mg clavulanic acid. AMK 625: Each tablet contains 500 mg of amoxicillin and 125 mg clavulanic acid. AMK 1000: Each tablet contains 875 mg of amoxicillin and 125 mg clavulanic acid. The amoxicillin is present as amoxicillin trihydrate and the clavulanic acid is ...

  4. Headquartered in France, Ipsen is a European pharmaceutical group which currently markets over 20 medicinal products throughout the world, mainly in Europe. The Group focuses its activity on the discovery & development of innovative products in specifically targeted disease areas with the aim of addressing unmet medical needs. Mailing Address.

  5. Four Star. Concise Prescribing Info. Contents. Entecavir. Indications/Uses. Chronic HBV infection in adults w/ compensated liver disease & evidence of active viral replication, persistently elevated serum ALT levels & histological evidence of active inflammation &/or fibrosis. Dosage/Direction for Use. Nucleoside-naïve patient 0.5 mg once daily.

  6. Generic Medicine Info. Indications and Dosage. Oral. Cough. Adult: 60 mg up to tid at intervals of at least 6 hours. Dosage recommendations may vary among countries or individual products (refer to specific product guidelines). Child: 2-12 years 1 mg/kg/dose up to tid at intervals of at least 6 hours.

  7. 2023年8月22日 · Unmet needs in the current treatment landscape of small-cell lung cancer: Small cell lung cancer (SCLC) is the most aggressive form of lung cancer, comprising approximately 10% to 15% of all cases. SCLC usually present at an advanced stage, with around 70% ...

  1. 相關搜尋

    林建名